Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
BRCA1/2 and Hereditary Breast, Ovarian and Pancreatic (HBOP) Cancer Variant Curation Expert Panels
Couch, F. J. & Spurdle, A. B.
8/10/22 → 7/31/24
Project: Research project
-
Resolving the cancer relevance of predisposition gene mutations
9/1/20 → 8/31/24
Project: Research project
-
Mayo Clinic Ovarian Cancer SPORE
Kaufmann, S. H., Bell, D. A., Bible, K. C., Cliby, W. A., Couch, F. J., Fields, A. P., Galanis, E., Goode, E. L., Haluska, P. R. J., Hartmann, L. C., Karnitz, L. M., Keeney, G., Knutson, K. L., Lengyel, E., Lingle, W. L., Long, H. J., Sherman, M. E., Moriarity, B. S., Block, M. S., Oberg, A. L., Peng, K., Shridhar, V. & Weroha, S.
9/1/09 → 8/31/24
Project: Research project
-
-
The contribution of RAD51C and RAD51D to breast and ovarian cancer
5/1/18 → 4/30/23
Project: Research project
-
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer
Leon-Ferre, R. A., Carter, J. M., Zahrieh, D., Sinnwell, J. P., Salgado, R., Suman, V. J., Hillman, D. W., Boughey, J. C., Kalari, K. R., Couch, F. J., Ingle, J. N., Balkenhol, M., Ciompi, F., van der Laak, J. & Goetz, M. P., Dec 2024, In: npj Breast Cancer. 10, 1, 25.Research output: Contribution to journal › Article › peer-review
Open Access -
Bilateral Oophorectomy and All-Cause Mortality inWomen With BRCA1 and BRCA2 Sequence Variations
Hereditary Breast Cancer Clinical Study Group, 2024, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
-
Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up
Stan, D. L., Kim, J. O., Schaid, D. J., Carlson, E. E., Kim, C. A., Sinnwell, J. P., Couch, F. J., Vachon, C. M., Cooke, A. L., Goldenberg, B. A. & Pruthi, S., Feb 2024, In: Cancer Prevention Research. 17, 2, p. 77-84 8 p.Research output: Contribution to journal › Article › peer-review
-
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY
Balmaña, J., Fasching, P. A., Couch, F. J., Delaloge, S., Labidi-Galy, I., O’Shaughnessy, J., Park, Y. H., Eisen, A. F., You, B., Bourgeois, H., Gonçalves, A., Kemp, Z., Swampillai, A., Jankowski, T., Sohn, J. H., Poddubskaya, E., Mukhametshina, G., Aksoy, S., Timcheva, C. V., Park-Simon, T. W., & 5 others , Apr 2024, In: Breast Cancer Research and Treatment. 204, 2, p. 237-248 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain
Hu, C., Huang, H., Na, J., Lumby, C., Abozaid, M., Holdren, M. A., Rao, T. J., Karam, R., Pesaran, T., Weyandt, J. D., Csuy, C. M., Seelaus, C. A., Young, C. C., Fulk, K., Heidari, Z., Morais Lyra, P. C., Couch, R. E., Persons, B., Polley, E., Gnanaolivu, R. D., & 6 others , Mar 7 2024, In: American journal of human genetics. 111, 3, p. 584-593 10 p.Research output: Contribution to journal › Article › peer-review